Lataa...
The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor
BACKGROUND: Monoamine oxidase-B (MAO-B) inhibitors are widely used in the treatment of Parkinson’s disease. They increase vital monoamine neurotransmitters in the brain. However, there is a need for safer natural reversible MAO inhibitors with MAO-B selectivity. Our previous studies showed that Psor...
Tallennettuna:
| Julkaisussa: | BMC Complement Altern Med |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5223566/ https://ncbi.nlm.nih.gov/pubmed/28069007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-016-1525-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|